Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Authors
Publication date
1 January 2020
Publisher
AMER SOC CLINICAL ONCOLOGY

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:3...
    Last time updated on 08/04/2021

    University of Groningen

    redirect
    oaioai:pure.rug.nl:publications/1...
    Last time updated on 24/11/2020

    ARTS repository - University of Groningen

    redirect
    oaioai:pure.rug.nl:openaire_cris_...
    Last time updated on 22/04/2023

    ARTS repository - University of Groningen

    redirect
    oaioai:pure.rug.nl:publications/4...
    Last time updated on 03/06/2022

    University of Groningen

    redirect
    oaioai:pure.rug.nl:publications/4...
    Last time updated on 24/11/2020

    ARTS repository - University of Groningen

    redirect
    oaioai:pure.rug.nl:publications/1...
    Last time updated on 03/06/2022

    ARTS repository - University of Groningen

    redirect
    oaioai:pure.rug.nl:openaire_cris_...
    Last time updated on 22/04/2023

    Kölner UniversitätsPublikationsServer

    redirect
    oaioai:USBKOELN.ub.uni-koeln.de:3...
    Last time updated on 08/04/2021